Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Dermatology and Therapy
Published in: Dermatology and Therapy 1/2016

Open Access 01-03-2016 | Review

Patterns of Reactions to Red Pigment Tattoo and Treatment Methods

Authors: Emily Forbat, Firas Al-Niaimi

Published in: Dermatology and Therapy | Issue 1/2016

Login to get access

Abstract

Tattoos are common and used extensively as either body art or cosmetic make-up; more rarely, they can be traumatic in nature. We have systemically analysed the literature for the patterns of red pigment tattoo reactions and their treatment options. Our search identified 18 articles; there was 1 non-randomised controlled trial, and the rest were small case studies. In total 139 patients were included within the studies. This review systematically analyses the different subsets of red tattoo reactions including lichenoid, dermatitis, granulomatous, pseudolymphomatous and miscellaneous reactions. The current evidence for the treatment for the above is presented. Dermatitis and lichenoid reactions appear to be the most common subtype of red pigment reactions with various treatment methods applied showing laser intervention to have some degree of success.
Literature
1.
Laumann AE. History and epidemiology of tattoos and piercings. Legislation in the United States. In: Dermatologic Complications with Body Art, 2009, p. 1–11.
2.
3.
Hutton Carlsen K, Serup J. Patients with tattoo reactions have reduced quality of life and suffer from itch. Skin Res Technol. 2015;21(1):101–7.CrossRefPubMed
4.
Mataix J, Silvestre JF. Cutaneous adverse reactions to tattoos and piercings. Actas Dermo Sifiliográficas Engl Ed. 2009;100(8):643–56.
5.
Jacob CI. Tattoo-associated dermatoses: a case report and review of the literature. Dermatol Surg. 2002;28(10):962–5.PubMed
6.
7.
Cruz FAM, Lage D, Frigério RM, et al. Reactions to the different pigments in tattoos: a report of two cases. An Bras Dermatol. 2010;85(5):708–11.CrossRefPubMed
8.
Sowden JM, Byrne JP, Smith AG, et al. Red tattoo reactions: X-ray microanalysis and patch-test studies. Br J Dermatol. 1991;124(6):576–80.CrossRefPubMed
9.
Ashinoff R, Levine VJ, Soter NA. Allergic reactions to tattoo pigment after laser treatment. Dermatol Surg. 1995;21(4):291–4.CrossRefPubMed
10.
11.
Balfour E, Olhoffer I, Leffell D, et al. Massive pseudoepitheliomatous hyperplasia: an unusual reaction to a tattoo. Am J Dermatopathol. 2003;25(4):338–40.CrossRefPubMed
12.
Garcovich S, Carbone T, Avitabile S, et al. Lichenoid red tattoo reaction: histological and immunological perspectives. Eur J Dermatol EJD. 2012;22(1):93–6.PubMed
13.
Corazza M, Zampino MR, Montanari A, et al. Lichenoid reaction from a permanent red tattoo: has nickel a possible aetiologic role? Contact Dermatitis. 2002;46(2):114–5.CrossRefPubMed
14.
Engel E, Santarelli F, Vasold R, et al. Modern tattoos cause high concentrations of hazardous pigments in skin. Contact Dermatitis. 2008;58(4):228–33.CrossRefPubMed
15.
Høgsberg T, Thomsen BM, Serup J. Histopathology and immune histochemistry of red tattoo reactions. Skin Res Technol ISBS Int Soc Digit Imaging Skin ISDIS Int Soc Skin Imaging ISSI. 2015;21(4):449–58.
16.
Kaur RR, Kirby W, Maibach H. Cutaneous allergic reactions to tattoo ink. J Cosmet Dermatol. 2009;8(4):295–300.CrossRefPubMed
17.
Goldstein N. Mercury–cadmium sensitivity in tattoos. A photoallergic reaction in red pigment. Ann Intern Med. 1967;67(5):984–9.CrossRefPubMed
18.
Kazandjieva J, Tsankov N. Tattoos: dermatological complications. Clin Dermatol. 2007;25(4):375–82.CrossRefPubMed
19.
Hutton Carlsen K, Serup J. Photosensitivity and photodynamic events in black, red and blue tattoos are common: a ‘Beach Study’. J Eur Acad Dermatol Venereol. 2014;28(2):231–7.CrossRefPubMed
20.
Serup J, Hutton Carlsen K. Patch test study of 90 patients with tattoo reactions: negative outcome of allergy patch test to baseline batteries and culprit inks suggests allergen(s) are generated in the skin through haptenization. Contact Dermatitis. 2014;71(5):255–63.CrossRefPubMed
21.
Antony FC, Harland CC. Red ink tattoo reactions: successful treatment with the Q-switched 532 nm Nd:YAG laser. Br J Dermatol. 2003;149(1):94–8.CrossRefPubMed
22.
23.
24.
Winkelmann RK, Harris RB. Lichenoid delayed hypersensitivity reactions in tattoos. J Cutan Pathol. 1979;6(1):59–65.CrossRefPubMed
25.
Litak J, Ke MS, Gutierrez MA, et al. Generalized lichenoid reaction from tattoo. Dermatol Surg. 2007;33(6):736–40.PubMed
26.
Sanghavi S, Dongre A, Khopkar U. Tattoo reactions—an epidemic on the surge: a report of 3 cases. Indian J Dermatol Venereol Leprol. 2013;79(2):231.CrossRefPubMed
27.
Campolmi P, Bassi A, Bonan P, et al. Cutaneous pseudolymphoma localized to black tattoo. J Am Acad Dermatol. 2011;65(5):e155–7.CrossRefPubMed
28.
Amann U, Luger TA, Metze D. Lichenoid pseudolymphomatous tattooing reaction. Hautarzt Z Für Dermatol Venerol Verwandte Geb. 1997;48(6):410–3.CrossRef
29.
Gardair Bouchy C, Kerdraon R, Kluger N, et al. Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo. Ann Pathol. 2013;33(4):273–7.CrossRefPubMed
30.
Jaehn T, Kaiser A, Grüneis C, et al. Pseudolymphatic allergic immune reaction after tattooing. Organ Deutschsprachigen Arbeitsgemeinschaft Für Mikrochir Peripher Nerven Gefässe Organ Ver Dtsch Plast Chir. 2014;46(6):379–82.
31.
Sweeney SA, Hicks LD, Ranallo N, et al. Perforating granulomatous dermatitis reaction to exogenous tattoo pigment: a case report and review of the literature. Am J Dermatopathol. 2013;35(7):754–6.CrossRefPubMed
32.
Godinho MM, Aguinaga F, Grynszpan R, et al. Granulomatous reaction to red tattoo pigment treated with allopurinol. J Cosmet Dermatol. 2015;14(3):241–5.CrossRefPubMed
33.
Litvinov IV, Sasseville D. Pyoderma gangrenosum triggered by red tattoo dye. CMAJ Can Med Assoc J J Assoc Medicale Can. 2014;186(12):935.CrossRef
34.
Greve B, Chytry R, Raulin C. Contact dermatitis from red tattoo pigment (quinacridone) with secondary spread. Contact Dermatitis. 2003;49(5):265–6.CrossRefPubMed
35.
Collins P, Evans AT, Gray W, et al. Pulmonary sarcoidosis presenting as a granulomatous tattoo reaction. Br J Dermatol. 1994;130(5):658–62.CrossRefPubMed
36.
Nawras A, Alsolaiman MM, Mehboob S, et al. Case report: systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-α treatment for chronic hepatitis C and review of the literature. Dig Dis Sci. 2002;47(7):1627–31.CrossRefPubMed
37.
Antonovich DD, Callen JP. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol. 2005;141(7):869–72.CrossRefPubMed
38.
Psaltis NM, Gardner RG, Denton WJ. Systemic sarcoidosis and red dye granulomatous tattoo inflammation after influenza vaccination: a case report and review of literature. Ocul Immunol Inflamm. 2014;22(4):314–21.CrossRefPubMed
39.
Sowden JM, Cartwright PH, Smith AG, Hiley C, Slater D. Sarcoidosis presenting with a granulomatous reaction confined to red tattoos. Clin Exp Dermatol. 1992;17(6):446–8.CrossRefPubMed
40.
Preda VA, Maley M, Sullivan JR. Mycobacterium chelonae infection in a tattoo site. Med J Aust. 2009;190(5):278–9.PubMed
41.
42.
Dang M, Hsu S, Bernstein E. Lichen planus or lichenoid tattoo reaction? Int J Dermatol. 1998;37(11):860–1.CrossRefPubMed
43.
Biro L, Klein W. Unusual complications of mercurial (cinnabar) tattoo: Generalized eczematous eruption following laceration of a tattoo. Arch Dermatol. 1967;96(2):165–7.CrossRefPubMed
44.
De Argila D, Chaves A, Moreno J. Erbium:Yag laser therapy of lichenoid red tattoo reaction. J Eur Acad Dermatol Venereol. 2004;18(3):332–3.CrossRefPubMed
45.
Kyanko ME, Pontasch MJ, Brodell RT. Red tattoo reactions: treatment with the carbon dioxide laser. J Dermatol Surg Oncol. 1989;15(6):652–6.CrossRefPubMed
46.
Madan V. Dermatological applications of carbon dioxide laser. J Cutan Aesthetic Surg. 2013;6(4):175–7.CrossRef
47.
Zemtsov A, Wilson L. CO2 laser treatment causes local tattoo allergic reaction to become generalized. Acta Derm Venereol. 1997;77(6):497.PubMed
48.
Green JB, Metelitsa AI. Optimizing outcomes of laser tattoo removal. Skin Ther Lett. 2011;16(10):1–3.
49.
50.
Taylor CR, Gange R, Dover JS, et al. Treatment of tattoos by q-switched ruby laser: a dose-response study. Arch Dermatol. 1990;126(7):893–9.CrossRefPubMed
51.
Lehmann G, Pierchalla P. Tattooing dyes. Dermatosen Beruf Umw Occup Environ. 1988;36(5):152–6.
52.
Vasold R, Naarmann N, Ulrich H, et al. Tattoo pigments are cleaved by laser light—the chemical analysis in vitro provide evidence for hazardous compounds. Photochem Photobiol. 2004;80(2):185–90.CrossRefPubMed
53.
Saunders H, O’Brien T, Nixon R. Textile dye allergic contact dermatitis following paraphenylenediamine sensitization from a temporary tattoo. Australas J Dermatol. 2004;45(4):229–31.CrossRefPubMed
54.
England RW, Vogel P, Hagan L. Immediate cutaneous hypersensitivity after treatment of tattoo with Nd:YAG laser: a case report and review of the literature. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2002;89(2):215–7.CrossRef
55.
Anderson RR, Geronemus R, Kilmer SL, et al. Cosmetic tattoo ink darkening. A complication of Q-switched and pulsed-laser treatment. Arch Dermatol. 1993;129(8):1010–4.CrossRefPubMed
56.
Herbich GJ. Ultrapulse carbon dioxide laser treatment of an iron oxide flesh-colored tattoo. Dermatol Surg. 1997;23(1):60–1.CrossRefPubMed
Metadata
Title
Patterns of Reactions to Red Pigment Tattoo and Treatment Methods
Authors
Emily Forbat
Firas Al-Niaimi
Publication date
01-03-2016
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 1/2016
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-016-0104-y

Other articles of this Issue 1/2016

Dermatology and Therapy 1/2016 Go to the issue

Brief Report

Amorolfine 5% Nail Lacquer Exhibits Potent Antifungal Activity Compared to Three Acid-Based Devices Indicated for the Treatment of Onychomycosis: An In Vitro Nail Penetration Assay

Case Report

A Case of Acrodermatitis Continua of Hallopeau Following Chronic Pustular Cheilitis

Original Research

Comparison of the Efficacy of Atopalm® Multi-Lamellar Emulsion Cream and Physiogel® Intensive Cream in Improving Epidermal Permeability Barrier in Sensitive Skin

Case Report

Molluscum Contagiosum Viral Infection Treated With a Dilute Povidone-Iodine/Dimethylsulfoxide Preparation

Review

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

Case Report

Carcinoma Cuniculatum of the Foot Invading the Bone Mimicking a Pseudo-Epitheliomatous Reaction to an Acute Osteomyelitis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits